Population-based prostate cancer trends in the United States: Patterns of change in the era of prostate-specific antigen

World Journal of Urology

Volumn 15, Issue 6, 1997, Pages 331-335

  Stephenson, Robert A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; CANCER REGISTRY; CANCER STAGING; HEALTH SURVEY; HUMAN; INCIDENCE; MALE; MORTALITY; PROSTATE TUMOR; REGISTER; REVIEW; UNITED STATES;

AGED; HUMANS; INCIDENCE; MALE; MORTALITY; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES; SEER PROGRAM; UNITED STATES;

EID: 0031298514     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01300179     Document Type: Article

References (17)

1. Carter HB, Pearson JD. Metter EJ, et al. (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267: 2215-2219
2. Catalona WJ, Smith DS, Basler JW (1993) Detection of organconfined prostate cancer is increased through prostate specific antigen-based screening. JAMA 270: 948-954
3. Gann PH, Hennekens CH, Stampfer MJ (1995) A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA 273: 289-294
4. Gilliland FD, Welsh DJ, Hoffman RM, Key CR (1994) Rapid rise and subsequent decline in prostate cancer incidence rates for New Mexico. 1989-1993. Cancer Epidemiol Biomarkers Prev 4: 797-800
5. Laara E, Day NE, Hakama M (1987) Trends in the mortality from cervical cancer in the Nordic countries: association with organized screening programs. Lancet I: 1247-1249
6. Mansfield JT, Soper TH, James BC. et al. (1996) Grade and stage migration in prostate cancer - pathologic findings in biopsy and radical prostatectomy specimens: population-based analysis from the Utah cancer registry. J Urol 155: 4ISA
7. Mansfield JT, Lignell E, Andendoro JD, Spencer SL, et al. ( 1997) The prevalence of PSA testina in the state of Utah. J Urol 157: 366
8. Merrill RM, Potosky AL, Feuer EJ (1996) Changing trends in US prostate cancer incidence rates. J Natl Cancer Inst 88: 1683-1685
9. Murray CL (1997) Re: The fall in incidence of prostate carcinoma; on the down side of a prostate specific antigen induced peak in incidence - data from the Utah cancer resistry. Cancer 79: 188-189
10. Newcomer LM, Stanford JL, Blumenstein BA, Brawer MK (1997) Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974-1994. J Urol (in press)
11. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics. 1996. CA 46: 5-27
12. Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics. 1997. CA 47: 5-27
13. Polednak AP (1997) Trends in prostate carcinoma incidence in Connecticut (1988-1994) by age and race. Cancer 79: 99-KB
14. Potosky AL, Miller BA, Albertsen PC, Kramer BS (1995) The role of increasina detection in the rising incidence of prostate cancer. JAMA 273: 548-552
15. Ries LAG, Miller BA, Hankey BF, et al. (1994) SEER cancer statistics review: tables and graphs, 1973-1991. Report NIH94-2789. National Institutes of Health, National Cancer Institute, Bethesda, Maryland
16. Sakr WA, Haas GP, Cassin BF, et al. (1993) The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 150: 379-385
17. Stephenson RA, Smart CR, Mineau GP, et al. (1996) The fall in incidence of prostate carcinoma: on the down side of a prostate specific antigen induced peak in incidence - data from the Utah cancer registry. Cancer 77: 1342-1348